Archive | Oral presentation

Increasing Access to Antimalaria Medicines in the Private Sector in Sub-Saharan Africa: Going Beyond Global Subsidies

Despite considerable efforts during the last millennium to eradicate or control malaria, it is still one of the most prevalent and devastating diseases in the tropics. This pervasive situation is compounded by the widespread parasite resistance to affordable medicines (chloroquine (CQ), sulphadoxinepyrimethamine (SP) and amodiaquine (AQ).

Continue Reading